Gomes, L. E. M.; Silva, F. A. R. da; Pascoal, L. B.; Ricci, R. L.; Nogueira, G.; Camargo, M. G.; Ayrizono, M. de L. S.; Fagundes, J. J.; Leal, R. F. Authors’ Reply – Comments: Serum Levels of Infliximab in Brazilian Patients With Crohn’s Disease: What Are the Reasons for Differences from Previous Studies?. Clinics 2019, 74, e1517. https://doi.org/10.6061/clinics/2019/e1517.